These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inorganic nitrite and chronic tissue ischaemia: a novel therapeutic modality for peripheral vascular diseases. Pattillo CB; Bir S; Rajaram V; Kevil CG Cardiovasc Res; 2011 Feb; 89(3):533-41. PubMed ID: 20851809 [TBL] [Abstract][Full Text] [Related]
6. Peripheral artery disease: current insight into the disease and its diagnosis and management. Olin JW; Sealove BA Mayo Clin Proc; 2010 Jul; 85(7):678-92. PubMed ID: 20592174 [TBL] [Abstract][Full Text] [Related]
7. New treatment options in intermittent claudication: the US experience. Hiatt WR Int J Clin Pract Suppl; 2001 Apr; (119):20-7. PubMed ID: 11355276 [TBL] [Abstract][Full Text] [Related]
8. Management of peripheral arterial disease and intermittent claudication. Schainfeld RM J Am Board Fam Pract; 2001; 14(6):443-50. PubMed ID: 11757887 [TBL] [Abstract][Full Text] [Related]
9. The US experience with cilostazol in treating intermittent claudication. Hiatt WR Atheroscler Suppl; 2005 Dec; 6(4):21-31. PubMed ID: 16275166 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease. Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195 [TBL] [Abstract][Full Text] [Related]
11. Management of patients with intermittent claudication. Olin JW Int J Clin Pract; 2002 Nov; 56(9):687-93. PubMed ID: 12469984 [TBL] [Abstract][Full Text] [Related]